Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
06/02/2004 | CN1501811A Compositions for stimulating cytokine secretion and inducing an immune response |
06/02/2004 | CN1501810A Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis |
06/02/2004 | CN1501799A Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids |
06/02/2004 | CN1501776A Microcapsules |
06/02/2004 | CN1501773A Liquid formulations for dernal application in treatment of parasitic insects in animals |
06/02/2004 | CN1500820A Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
06/02/2004 | CN1500532A Product capable of emitting far infrared and method of using far infrared |
06/02/2004 | CN1500524A Vehicle for topical delivery of anti-inflammatory compounds |
06/02/2004 | CN1500522A Suppository for treating gynecopathy and its preparation technology |
06/02/2004 | CN1500521A Keep-in-mouth tablet for oral ulcer and preparation method |
06/02/2004 | CN1500518A Freeze drying powder containing red ginseng and accessory piece for injection |
06/02/2004 | CN1500500A Freeze-dry snow lotus powder for venous injection and its preparation method |
06/02/2004 | CN1500492A Veterinary antiparasite suspension injection |
06/02/2004 | CN1500491A Release-controlled oral Roxithromycin formulation |
06/02/2004 | CN1500490A Rinsing liquid for endometritis and its preparation method |
06/02/2004 | CN1500489A Notoginseng drop pills for calming nerve and curing insomnia etc. and preparation method |
06/02/2004 | CN1500488A Oral colon-positioned medicine composition for curing bacillary dysentery |
06/02/2004 | CN1500485A Solid dispersed matter of hydroxyl-camptothecin , its preparation and formulation |
06/02/2004 | CN1500478A Release delayed solid oral prophylactic or pregnancy stopping pill and its use |
06/02/2004 | CN1500477A Quick result aerosol with plant aroma and its preparation |
06/02/2004 | CN1500476A Microporous film distilled condensation method of aqueous traditional Chinese medicine extract |
06/02/2004 | CN1500475A Diffusional implantable delivery system |
06/02/2004 | CN1500474A Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active principle stabilized by at least one maleic anhydride copolymer |
06/02/2004 | CN1152042C Partial or full A agonists-N heterocyclic 5' thio substituted adenosine devivatives |
06/02/2004 | CN1151866C Microparticles produced from cyclic olefin copolymers and their use for the controlled release of active agents |
06/02/2004 | CN1151845C Crystallographically stable amorphous sephalosporin compositions and process for producing the same |
06/02/2004 | CN1151844C Preparation of pharmaceutical active granules |
06/02/2004 | CN1151839C In-colon release-controlled thymopeptide capsule and process for extracting and separating thymopeptide |
06/02/2004 | CN1151836C Compounds and compositions for delivering active agents |
06/02/2004 | CN1151831C Decoction of external use for curing lupus erythematosus |
06/02/2004 | CN1151827C Dressed plaster for treating facial palsy and its preparation |
06/02/2004 | CN1151822C Liquid medicine for treating traumatic injury |
06/02/2004 | CN1151808C Snuff inhalant for treating cardiovascular and cerebrovascular disease |
06/02/2004 | CN1151807C Traditional Chinese-medicinal spray for treating chronic pharyngolaryngitis and its preparing process |
06/02/2004 | CN1151799C Bacterial membrane fractions with adjuvant effect |
06/02/2004 | CN1151794C Medicinal compositions for treating eye diseases |
06/02/2004 | CN1151791C Sustained-release composition containing cefaclor |
06/02/2004 | CN1151788C Carbediolo-galenics |
06/02/2004 | CN1151786C Treating urinary incontinence using (s)-oxybutynin and (s) -desethyloxybutynin |
06/02/2004 | CN1151783C Delayed-release dosage forms of sertraline |
06/02/2004 | CN1151782C Medicinal injection liquid of anaesthesia induction and keeping and sedation of mammalian |
06/02/2004 | CN1151780C Solubility paramete based drug delivery system and method for altering drug saturation concentration |
06/02/2004 | CN1151779C Two-piece capsule for receiving pharmaceutical preparations for powder inhalers |
06/02/2004 | CN1151778C Pharmaceutical composition comprising entacapone or nitecapone as well as cross-linked cellulose derivative |
06/02/2004 | CN1151777C Preparation for transport of active substance across barriers |
06/02/2004 | CN1151776C Clear hydroalcoholic multivitamin solution containing physiologically effective amounts of beta-carotene |
06/02/2004 | CN1151775C Method of treating dry eye disease with purinergic receptor agonists |
06/01/2004 | US6743930 Kernel oil from plant kernel, process for extracting same, pharmaceutical composition and thereof |
06/01/2004 | US6743900 Viral protein antigen (especially influenza virus hemagglutinin), proteosome preparation and detergent; removing detergent by diafiltration or ultrafiltration |
06/01/2004 | US6743880 Introducing monomeric 2- hydroxyethyl methacrylate containing ethylene glycol, dimethacrylate impurities, and atleast one acrylic or methacrylic acid into a solution of water and alcohol, and copolymerizing the monomers |
06/01/2004 | US6743827 Method for preparing colloidal solution of bismuth sodium tartrate |
06/01/2004 | US6743826 Delivery of compounds having poor water solubility; binding affinity to plasma proteins by way of non-covalent bonds; serum albumin and gamma globulin; paclitaxel, amphotericin b, camptothecin, carbamazepine, cyclosporin a; propofol |
06/01/2004 | US6743801 1,2,3,6-tetrahydropyrimidine-2-one compositions and therapeutic methods therewith for pain and inflammation |
06/01/2004 | US6743783 Pharmaceutical compositions comprising poly-β-1→4-N-acetylglucosamine |
06/01/2004 | US6743779 Methods for delivering compounds into a cell |
06/01/2004 | US6743775 Slow release formulations comprising anionic polysaccharide |
06/01/2004 | US6743521 Multifunctional polymeric tissue coatings |
06/01/2004 | US6743459 Oil phase containing a diacylglycerol and a crystallization inhibitor; excellent shelf-life at low temperatues, good in appearance and flavor, useful as a diet or food for improving lipid metabolism |
06/01/2004 | US6743448 Fineness particle size; hormone replacement therapy |
06/01/2004 | US6743447 Pulverulent mannitol and process for preparing it |
06/01/2004 | US6743446 Sustained release |
06/01/2004 | US6743445 Low temperature coatings |
06/01/2004 | US6743444 Method of making microencapsulated DNA for vaccination and gene therapy |
06/01/2004 | US6743443 Tablets immediately disintegrating in the oral cavity |
06/01/2004 | US6743442 Bioavailability; sustained release |
06/01/2004 | US6743441 Controlling concentration; side effect reduction |
06/01/2004 | US6743439 Cationic preservative, cationic drug and a sulfonated styrene/maleic anhydride copolymer |
06/01/2004 | US6743437 Implant device with a retinoid for improved biocompatibility |
06/01/2004 | US6743436 Anesthetic composition for intravenous injection comprising propofol |
06/01/2004 | US6743415 Delivery of anti-migraine compounds through an inhalation route |
06/01/2004 | US6743414 Bone disorders; osteoporosis |
06/01/2004 | US6743413 Suspension aerosol formulations |
06/01/2004 | US6742646 Systems, methods and apparatuses for manufacturing dosage forms |
06/01/2004 | US6742520 Intrauterine contraceptive device |
06/01/2004 | CA2315871C Methods, compositions, and kits for enhancing female sexual desire and responsiveness |
06/01/2004 | CA2270004C Stable mitoxantrone solutions |
06/01/2004 | CA2196922C Pharmaceutically stable oxaliplatinum preparation |
06/01/2004 | CA2075720C Hemorroanzi |
05/27/2004 | WO2004043970A1 Novel lipophilic compounds and uses thereof |
05/27/2004 | WO2004043918A2 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
05/27/2004 | WO2004043513A2 Surface dissolution and/or bulk erosion controlled release compositions and devices |
05/27/2004 | WO2004043504A1 Moisture-activated adhesives for medical applications |
05/27/2004 | WO2004043486A1 An acqueous pharmaceutical formulation comprising the thrombin inhibitor melagatran and use of the formulation in the manufacture of a medicament for use by nasal administration in treating thromboembolism |
05/27/2004 | WO2004043480A2 Intraocular administration of cyclosporin a for the treatment of macular degeneration, retinopathy or retinitis pigmentosa |
05/27/2004 | WO2004043477A1 Dietary supplement comprising parthenolide |
05/27/2004 | WO2004043476A1 Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms |
05/27/2004 | WO2004043470A1 The use of an anti-allergy agent and a steroid to treat allergic rhinitis |
05/27/2004 | WO2004043449A1 Pharmaceutical pellets comprising tamsulosin and a process for making the same |
05/27/2004 | WO2004043448A1 Pharmaceutical pellets comprising tamsulosin |
05/27/2004 | WO2004043446A2 Combination product for controlling insect pests |
05/27/2004 | WO2004043445A1 Topical parasiticide formulations and methods of treatment |
05/27/2004 | WO2004043442A1 Stable aerosol formulation of peptides and protein with non-cfc propellants |
05/27/2004 | WO2004043441A1 Polymeric microparticulates for sustained release of drug and their preparation methods |
05/27/2004 | WO2004043440A1 Fast-disintegrating solid dosage forms being not friable and comprising pullulan |
05/27/2004 | WO2004043439A1 Improved formulations containing substituted imidazole derivatives |
05/27/2004 | WO2004043438A1 Shape-retentive hydrogel particle aggregates and their uses |
05/27/2004 | WO2004043437A1 Method for the preparation of paclitaxel solid dispersion by using the supercritical fluid process and paclitaxel solid dispersion prepared thereby |
05/27/2004 | WO2004043436A1 Medicinal aerosol comprising plant essential oil and its preparation |
05/27/2004 | WO2004043435A2 Systemic delivery of antiviral agents |
05/27/2004 | WO2004043434A1 Oral testosterone delivery system with improved sustained release |